EGFR and non-small cell lung carcinoma: <i>Materials and Methods</i>: This retrospective multicenter study included 332 patients with metastatic NSCLC harboring oncogenic alterations (EGFR, ALK, ROS1, KRAS, and others) from eight oncology centers in Türkiye.